Conzerol Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Conzerol General Information

Description

Manufacturer of a medical product intended to treat molluscum disease. The company's product is based on a blend of phytochemical and antiviral compounds found in nature, which help to reduce lesions and pain caused by the disease, enabling patients to gain relief from molluscum faster with less pain.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 815 Eyrie Drive
  • Suite 3
  • Oviedo, FL 32765
  • United States
+1 (855)
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • 815 Eyrie Drive
  • Suite 3
  • Oviedo, FL 32765
  • United States
+1 (855)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Conzerol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 11-Jun-2025 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view Conzerol’s complete valuation and funding history, request access »

Conzerol FAQs

  • When was Conzerol founded?

    Conzerol was founded in 2015.

  • Where is Conzerol headquartered?

    Conzerol is headquartered in Oviedo, FL.

  • What industry is Conzerol in?

    Conzerol’s primary industry is Pharmaceuticals.

  • Is Conzerol a private or public company?

    Conzerol is a Private company.

  • What is Conzerol’s current revenue?

    The current revenue for Conzerol is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »